AHC
BSX icon

Adell Harriman & Carpenter’s Boston Scientific BSX Stock Holding History

Adell Harriman & Carpenter’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Sell
10,059
-20,450
-67% -$1.11M 0.02% 131
2026
Q1 		$1.91M Sell
30,509
-24,646
-45% -$1.97M 0.12% 90
2025
Q4 		$5.26M Sell
55,155
-1,331
-2% -$130K 0.31% 59
2025
Q3 		$5.51M Buy
56,486
+11,007
+24% +$1.14M 0.33% 59
2025
Q2 		$4.88M Buy
45,479
+19,735
+77% +$2M 0.32% 62
2025
Q1 		$2.6M Buy
+25,744
New +$2.59M 0.2% 76

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Adell Harriman & Carpenter's BSX Position: Q2 2026 in Review

Adell Harriman & Carpenter reduced its Boston Scientific (BSX) stake by 67% in Q2 2026, selling an estimated $1.11M and leaving 10,059 shares worth $429K. The position accounts for 0.02% of the portfolio, ranked #131.

Adell Harriman & Carpenter first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.51M in Q3 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Adell Harriman & Carpenter held 10,059 shares of Boston Scientific worth $429K as of Q2 2026.
  • Adell Harriman & Carpenter sold 20,450 Boston Scientific shares in Q2 2026, an estimated $1.11M.
  • Boston Scientific made up 0.02% of Adell Harriman & Carpenter's portfolio in Q2 2026, its #131 holding.
  • Adell Harriman & Carpenter first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Adell Harriman & Carpenter's Boston Scientific position peaked at $5.51M in Q3 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Adell Harriman & Carpenter's 13F filing for Q2 2026, filed 4 Aug 2026.